STERIS
Rating
Updated: Aug 17, 2026Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. The company operates through three segments: Healthcare, Applied Sterilization Techno...
Latest News
6 days ago · seekingalpha.com
STERIS plc (STE) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSTERIS plc (STE) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
20 days ago · globenewswire.com
STERIS to Present at the Morgan Stanley Healthcare ConferenceDublin, Ireland, Sept. 01, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will participate in the Morgan Stanley Healthcare Conference in New York City on Tuesday, September 15, 2026.
1 month ago · zacks.com
Can STERIS Stock Deliver as Its $600 Million Chemistry Bet Scales?STE is betting $600 million on a new chemistry center to boost capacity and efficiency, but higher spending and execution risks loom.
1 month ago · zacks.com
Should Investors Buy STERIS as Growth Meets Reasonable Valuation?STE enters fiscal 2027 with solid growth, recurring healthcare demand and better margins, but tariffs and investment needs temper the valuation case.
2 months ago · seekingalpha.com
STERIS plc (STE) Q1 2027 Earnings Call TranscriptSTERIS plc (STE) Q1 2027 Earnings Call Transcript
2 months ago · zacks.com
STE Q1 Earnings Beat, Revenues Miss, Stock Dips in Aftermarket TradingSTERIS beats fiscal Q1 earnings estimates as sales rise 7.3%, but a modest revenue miss sends shares 2.4% lower after hours.
2 months ago · zacks.com
Here's What Key Metrics Tell Us About Steris (STE) Q1 EarningsWhile the top- and bottom-line numbers for Steris (STE) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
2 months ago · zacks.com
Steris (STE) Q1 Earnings Surpass EstimatesSteris (STE) came out with quarterly earnings of $2.59 per share, beating the Zacks Consensus Estimate of $2.54 per share. This compares to earnings of $2.34 per share a year ago.
2 months ago · globenewswire.com
STERIS Announces Financial Results for Fiscal 2027 First QuarterDUBLIN, IRELAND, Aug. 05, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2027 first quarter ended June 30, 2026. Total revenue for the first quarter of fiscal 2027 increased 7% to $1.5 billion compared with $1.4 billion in the first quarter of fiscal 2026. Constant currency organic revenue growth was 6% in the first quarter.
2 months ago · reuters.com
Steris to invest $600 million in new North Carolina chemicals manufacturing hubMedical equipment maker Steris said on Wednesday it will invest $600 million to build a manufacturing and distribution hub in North Carolina for chemicals used by healthcare and pharmaceutical customers.
Analyst Summary
Add to Watchlist
Select watchlists to add or remove STE